Page last updated: 2024-09-05

erlotinib hydrochloride and Colitis

erlotinib hydrochloride has been researched along with Colitis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Appleyard, CB; Coppola, D; Cruz, ML; Isidro, AA; Pagán, B; Ren, Y; Wu, J	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Colitis

Article	Year
Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model. World journal of gastroenterology, 2011, Nov-28, Volume: 17, Issue:44 Topics: Animals; Cell Line; Cell Proliferation; Colitis; Colon; Colonic Neoplasms; Disease Models, Animal; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Humans; Male; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid	2011

Article

Year

Erlotinib inhibits progression to dysplasia in a colitis-associated colon cancer model.

World journal of gastroenterology, 2011, Nov-28, Volume: 17, Issue:44

Topics: Animals; Cell Line; Cell Proliferation; Colitis; Colon; Colonic Neoplasms; Disease Models, Animal; Disease Progression; ErbB Receptors; Erlotinib Hydrochloride; Humans; Male; Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Trinitrobenzenesulfonic Acid

2011